SCHEMBL18166637

SCHEMBL18166637

Cn1c(=O)c2c(ncn2CC(=O)Nc2nnc(-c3ccc(Cl)cc3)s2)n(C)c1=O

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.67
▸ RXFP1 Q9HBX9 3/20 0.65
▸ POLB P06746 1/20 0.63
▸ THRB P10828 1/20 0.62
▸ PORCN Q9H237 3/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ HTT P42858 1/20 0.61
▸ TP53 P04637 1/20 0.59
▸ MAPT P10636 2/20 0.59
▸ KMT2A Q03164 1/20 0.58
▸ LMNA P02545 2/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ TRPA1 O75762 1/20 0.57
▸ CYP1A2 P05177 1/20 0.56
▸ MAPK1 P28482 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18166715 0.91 HSD17B10 (0.67) HSD17B10RXFP1THRBPORCNALDH1A1
SCHEMBL18166765 0.90 HSD17B10 (0.78) HSD17B10RXFP1PORCNALDH1A1CYP2C9
SCHEMBL10114157 0.84 POLB (0.60) HSD17B10RXFP1POLBTHRBPORCN
SCHEMBL4527599 0.84 POLB (0.62) HSD17B10RXFP1POLBTHRBPORCN
SCHEMBL3266103 0.83 MAPT (0.79) RXFP1POLBTHRBPORCNTP53
SCHEMBL10114021 0.83 TRPA1 (0.80) RXFP1POLBTHRBPORCNTP53
SCHEMBL15727746 0.81 HSD17B10 (0.75) HSD17B10RXFP1THRBALDH1A1CYP2C9
SCHEMBL15384474 0.80 POLB (0.65) RXFP1POLBTHRBPORCNTP53
SCHEMBL20161605 0.80 POLB (0.65) RXFP1POLBTHRBPORCNTP53
SCHEMBL17200781 0.80 RXFP1 (0.68) HSD17B10RXFP1THRBPORCNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663295-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL ELI LILLY AND CO. (US) 2020-06-10 — — EP disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 — — EP disclosed
Send feedback